Vilaprisan

N/A

Report date: 2026/03/27 20:01:50
NME

Base Information

Drug NameVilaprisan
Drug Alias NameVilaprisanum维拉立生维拉利桑IN59K53GI9BAY-1002670 +[9
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor antagonists
TargetsProgesterone receptor
Therapy Area/IndicationsEndometriosisUterine NeoplasmsLeiomyoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[41
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Inactive CompaniesBayer AG
Active IndicationsUterine Neoplasms
Inactive IndicationsEndometriosisLeiomyoma

Other Information

ATC CodeN/A
Related LinksN/A